1. Home
  2. SGI vs NBIX Comparison

SGI vs NBIX Comparison

Compare SGI & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SGI

Somnigroup International Inc.

HOLD

Current Price

$70.01

Market Cap

14.0B

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$155.33

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGI
NBIX
Founded
1846
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0B
15.5B
IPO Year
2003
1996

Fundamental Metrics

Financial Performance
Metric
SGI
NBIX
Price
$70.01
$155.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
22
Target Price
$97.88
$180.91
AVG Volume (30 Days)
3.3M
1.1M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
0.90%
N/A
EPS Growth
N/A
41.95
EPS
1.01
3.30
Revenue
$2,754,400,000.00
$161,626,000.00
Revenue This Year
$7.30
$24.73
Revenue Next Year
$4.99
$13.14
P/E Ratio
$69.18
$47.16
Revenue Growth
N/A
977.51
52 Week Low
$60.39
$122.14
52 Week High
$98.56
$186.12

Technical Indicators

Market Signals
Indicator
SGI
NBIX
Relative Strength Index (RSI) 60.93 44.49
Support Level $69.30 $152.67
Resistance Level $70.54 $161.29
Average True Range (ATR) 2.16 3.81
MACD 1.01 0.77
Stochastic Oscillator 95.58 47.31

Price Performance

Historical Comparison
SGI
NBIX

About SGI Somnigroup International Inc.

Somnigroup International Inc is a bedding company, dedicated to improving people's lives through good sleep. With superior capabilities in design, manufacturing, distribution and retail, It delivers breakthrough sleep solutions and serves the evolving needs of consumers in more than 100 countries world-wide through its fully-owned businesses Mattress Firm, Tempur Sealy North America and Tempur Sealy International. The company's portfolio includes the brand such as Tempur-Pedic, Sealy and Stearns & Foster, and its Multinational omnichannel platform enables the company to meet consumers wherever shop, offering a personal connection and innovation to provide a retail experience and tailored solutions.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: